Cargando…

Modelling lung cancer diagnostic pathways using discrete event simulation

The United Kingdom has one of the poorest lung cancer survival rates in Europe. In this study, to help design and evaluate a single lung cancer pathway (SCP) for Wales, existing diagnostic pathways and processes have been mapped and then modelled with a discrete event simulation. The validated model...

Descripción completa

Detalles Bibliográficos
Autores principales: England, Tracey, Harper, Paul, Crosby, Tom, Gartner, Daniel, Arruda, Edilson F., Foley, Kieran, Williamson, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901409/
https://www.ncbi.nlm.nih.gov/pubmed/36760877
http://dx.doi.org/10.1080/17477778.2021.1956866
_version_ 1784883025291509760
author England, Tracey
Harper, Paul
Crosby, Tom
Gartner, Daniel
Arruda, Edilson F.
Foley, Kieran
Williamson, Ian
author_facet England, Tracey
Harper, Paul
Crosby, Tom
Gartner, Daniel
Arruda, Edilson F.
Foley, Kieran
Williamson, Ian
author_sort England, Tracey
collection PubMed
description The United Kingdom has one of the poorest lung cancer survival rates in Europe. In this study, to help design and evaluate a single lung cancer pathway (SCP) for Wales, existing diagnostic pathways and processes have been mapped and then modelled with a discrete event simulation. The validated models have been used to provide key performance indicators and to examine different diagnostic testing strategies. Under the current diagnostic pathways, the mean time to treatment was 72 days for surgery patients, 56 days for chemotherapy patients, and 61 days for radiotherapy patients. Our research demonstrated that by ensuring that the patient attends their first outpatient appointment within 7 days and streamlining the diagnostic tests would have the potential to remove approximately 11 days from the current lung cancer pathway resulting in a 21% increase in patients receiving treatment within the Welsh Government set target of 62 days.
format Online
Article
Text
id pubmed-9901409
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-99014092023-02-07 Modelling lung cancer diagnostic pathways using discrete event simulation England, Tracey Harper, Paul Crosby, Tom Gartner, Daniel Arruda, Edilson F. Foley, Kieran Williamson, Ian J Simul Reseach Article The United Kingdom has one of the poorest lung cancer survival rates in Europe. In this study, to help design and evaluate a single lung cancer pathway (SCP) for Wales, existing diagnostic pathways and processes have been mapped and then modelled with a discrete event simulation. The validated models have been used to provide key performance indicators and to examine different diagnostic testing strategies. Under the current diagnostic pathways, the mean time to treatment was 72 days for surgery patients, 56 days for chemotherapy patients, and 61 days for radiotherapy patients. Our research demonstrated that by ensuring that the patient attends their first outpatient appointment within 7 days and streamlining the diagnostic tests would have the potential to remove approximately 11 days from the current lung cancer pathway resulting in a 21% increase in patients receiving treatment within the Welsh Government set target of 62 days. Taylor & Francis 2021-08-02 /pmc/articles/PMC9901409/ /pubmed/36760877 http://dx.doi.org/10.1080/17477778.2021.1956866 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reseach Article
England, Tracey
Harper, Paul
Crosby, Tom
Gartner, Daniel
Arruda, Edilson F.
Foley, Kieran
Williamson, Ian
Modelling lung cancer diagnostic pathways using discrete event simulation
title Modelling lung cancer diagnostic pathways using discrete event simulation
title_full Modelling lung cancer diagnostic pathways using discrete event simulation
title_fullStr Modelling lung cancer diagnostic pathways using discrete event simulation
title_full_unstemmed Modelling lung cancer diagnostic pathways using discrete event simulation
title_short Modelling lung cancer diagnostic pathways using discrete event simulation
title_sort modelling lung cancer diagnostic pathways using discrete event simulation
topic Reseach Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901409/
https://www.ncbi.nlm.nih.gov/pubmed/36760877
http://dx.doi.org/10.1080/17477778.2021.1956866
work_keys_str_mv AT englandtracey modellinglungcancerdiagnosticpathwaysusingdiscreteeventsimulation
AT harperpaul modellinglungcancerdiagnosticpathwaysusingdiscreteeventsimulation
AT crosbytom modellinglungcancerdiagnosticpathwaysusingdiscreteeventsimulation
AT gartnerdaniel modellinglungcancerdiagnosticpathwaysusingdiscreteeventsimulation
AT arrudaedilsonf modellinglungcancerdiagnosticpathwaysusingdiscreteeventsimulation
AT foleykieran modellinglungcancerdiagnosticpathwaysusingdiscreteeventsimulation
AT williamsonian modellinglungcancerdiagnosticpathwaysusingdiscreteeventsimulation